Analysis of Revenues
Paying user area
Try for free
Kimberly-Clark Corp. pages available for free this week:
- Common-Size Income Statement
- Common-Size Balance Sheet: Assets
- Analysis of Solvency Ratios
- Common Stock Valuation Ratios
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Price to Earnings (P/E) since 2005
- Analysis of Debt
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Kimberly-Clark Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Revenues as Reported
Kimberly-Clark Corp., income statement, revenues
US$ in millions
| 12 months ended: | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Baby and child care products | |||||||||||
| Consumer tissue products | |||||||||||
| Away-from-home professional products | |||||||||||
| All other | |||||||||||
| Net sales |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).
The data reveals several notable trends in the revenue performance of different product segments over the five-year period ending in 2020. Overall, net sales exhibit a gradual increase, growing from 18,200 million US dollars in 2016 to 19,100 million US dollars in 2020, indicating steady but moderate company growth.
- Baby and Child Care Products
- This segment demonstrates relative stability, with revenues hovering around 6,300 to 6,400 million US dollars throughout the period. After a slight dip in 2017, revenues remained consistent until a modest increase was recorded in 2020, returning to the 2016 level.
- Consumer Tissue Products
- Consumer tissue products show a mildly volatile but generally positive trend. The revenue slightly decreased from 6,000 million in 2016 to 5,900 million in 2017, then recovered to 6,000 million in 2018 and 2019 before experiencing a significant jump to 6,700 million in 2020, suggesting a strong performance in the latest year.
- Away-from-Home Professional Products
- Revenues in this category experienced fluctuations across the period. Starting at 3,100 million in 2016, the figure rose to 3,400 million by 2018, followed by a decline to 3,000 million in 2020. This pattern points to a peak in 2018 with a gradual downturn thereafter.
- All Other Segments
- The "All other" category shows a consistent upward trajectory, increasing steadily each year from 2,700 million in 2016 to 3,000 million in 2020. This stable growth suggests expanding contributions from miscellaneous or smaller revenue streams.
In summary, the company’s net sales growth is driven mainly by the notable increase in consumer tissue products and the steady rise in other segments, despite some declines in away-from-home professional products. The baby and child care products segment remains stable, contributing consistently to total revenues. The observed revenue dynamics may reflect shifting market demands or strategic focus over time.